Lung cancer
52,777 new cases in France in 2023 1
What is it?
Most lung cancers start in the cells lining the bronchi. A distinction is made between “non-small cell” cancers (about 85 %, including adenocarcinoma, also common in people who do not smoke) and “small cell” cancers (about 15 %), which progress faster 2.
How it develops
The tumor first grows in the lung, reaches the lymph nodes in the chest and may then spread to other organs (bones, brain, liver). Early stages rarely cause signs 2.
How long does it take to develop?
The phase during which a CT scan can detect the tumor before symptoms is estimated to last an average of 3 to 5 years in men and 3 to 6 years in women 3.
Risk factors
- Tobacco, responsible for about 8 in 10 cases, even with low consumption
- Secondhand smoke
- Radon, a naturally occurring gas found in some regions (Bretagne, Massif central, Vosges, Corse)
- Certain occupational exposures: asbestos, chromium, arsenic, nickel, diesel exhaust
What helps protect you: Stopping smoking: the risk is halved after 5 years without smoking 4.
Signs that should prompt a visit to your doctor
In the early stages
- No symptoms for a very long time
As it progresses
- A cough that changes or persists
- Coughing up blood
- Shortness of breath
At an advanced stage
- Signs vary depending on the organs affected
Across several stages
Fatigue, loss of appetite and weight
These signs do not mean you have cancer: they may have other causes. Unsure? Talk to your doctor.
⁵A cough that persists or changes, sometimes with traces of blood, chest pain, breathlessness, a hoarse voice lasting several weeks, repeated respiratory infections 2.
Detected early or at a later stage
In France, nearly 6 in 10 lung cancers are found at the metastatic stage 6. In the United States: 24 % localized (confined to the lung), 21 % regional (lymph nodes in the chest), 51 % distant 7.
5-year survival by stage
At the localized stage, survival is about 6 times higher than at the metastatic stage 7.
Approximate correspondence with the clinical classification (TNM/FIGO); this varies depending on the tumour's characteristics.
Screening in France
The IMPULSION pilot program, led by INCa since 2025-2026: low-dose chest CT scans for current and former smokers aged 50 to 74, with support to stop smoking. About 20 000 participants across 5 regions 68.
Monitoring for people at risk
Outside the pilot program, screening is not recommended. The main steps are stopping smoking, measuring radon levels at home and monitoring people with occupational exposure 4.

Prevonco is currently available in France only.
An aid to the early detection of 16 cancers
No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.
Pre-register for free →Frequently asked questions
Do I need a prescription?
No. With Prevonco, you do not need a prescription: after ordering online, a unique code gives you access to the test at one of our partner laboratories. In France, some laboratory tests can be carried out at your request, without a prescription.
No prescription, but still a doctor: they remain central to the process. Your result is sent to the doctor you selected from our panel, who will explain it during a 30-minute video consultation, included whatever the result.
Are you receiving care for cancer? Speak directly to your oncologist: they can prescribe this test without going through Prevonco.
For any questions about your situation, or if you have symptoms, your doctor remains your first point of contact.
What if my level is high?
A high level tends to be a strong signal. It is not a conclusion: its cause needs to be investigated with a doctor.⁹
Your result is sent to the doctor you selected from our panel. They will explain it during the 30-minute video consultation included in the price. Further investigations prescribed by a doctor can help identify the cause.⁹
What if the level is intermediate? It may not be related to cancer (smoking, an inflammatory condition, etc.). Other blood tests may be suggested; if they are normal, a repeat check is planned at 12 months. You will never be left to face your result alone.⁹
What if my level is low?
That is reassuring, but no test is perfect: a low level does not rule everything out.⁹
If you have no symptoms, no specific follow-up is recommended after a low result. The risk of a false negative varies by cancer type.⁹
Your doctor, who is trained in functional medicine and specialises in prevention, will help you explore any concerns or symptoms during the 30-minute video consultation.⁹
Keep up with your usual screening: respond to invitations for organised screening programmes, and see your doctor if a symptom appears.⁹
How long will it take to get my results?
The laboratory analysis takes 30 days. Your full results are presented by a doctor trained in functional medicine during a 30-minute consultation included in your package.
You choose the date and time slot that suit you for this appointment.
Prevonco is currently available in France only.
An aid to the early detection of 16 cancers
No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.
Pre-register for free →General information for educational purposes: it does not replace your doctor's advice. An aid to early detection: it does not replace organised screening, imaging tests or your doctor's advice.
Sources
- 1.INCa, Panorama des cancers en France, 2026
- 2.American Cancer Society, What Is Lung Cancer?
- 3.ten Haaf et al., Cancer Epidemiology, Biomarkers & Prevention, 2015 (NLST and PLCO trials)
- 4.Santé.fr, cancer du poumon
- 5.INCa (cancer.fr, 27/03/2026; tool for doctors 2025)
- 6.INCa, fiche médecin généraliste – dépistage du cancer du poumon, 2025
- 7.NCI SEER, Cancer Stat Facts – Lung and Bronchus Cancer (2016-2022)
- 8.ARS PACA, lancement du programme pilote IMPULSION
- 9.biodena.care